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Abstract
Methylphenidate and bupropion have been demonstrated as being iffective adjuncts to
serotonin reuptake inhibitors in the treatment qfdepression (1,2). The use ofthese medications in
the.formcftriple therapyfor cases cfsevere refractory illness has not been reported. We present the
case of a depressed patient whose condition was resistant to several .forms qf monotherapy ,
monotherapy with "standard" augmentation and ECT. Afler only a partial response toJluoxetine
and methylphenidate, bupropion was added, resulting in full, sustained remission.
CASE REPORT
BL is a middle ag ed male with dysthymia and severe recurren t major depres-
sion, and a negative past medical history. Hi s illness had partially responded to
fluox etine, desipramine, ph en elzine and paroxetine; however, his chro nic low-grade
depression and almost consta n t suicidal preoccupation never resolved . He received
ECT, also with an initial good response, but later relap sed with a return of his
episod ic severe depression. Subsequent trials of bupropi on with liothyro nine au g-
mentation, venlafaxine, and a combina tion of se r t raline , nortriptylin e a nd lithium all
failed .
Sin ce th e initial fluox etine trial was on ly two weeks time in len gth, it was
restarted without significant improvement. Methylphenidate was thus added and
titrated to a dos e of 10 mg bid . On this regimen, BL expe rie nce d improvemen t in
ene rgy level and demonstrated a brighter affect. Again, however, his low-grade
depression and sui cidal preoccupation continued. Bupropion, was th en started and
th en titrated to a maximum dos e of 100 mg bid . The triple th erap y was well-
tol erated , and brought about significant clinical improvem ent. His ene rgy level
improved further, and his dysphporia, sleep disturbance, anhedonia a nd suic ida l
ideation gradually resolved. At two-month follow-up, th ese improvem en ts were
sustained. Most importantly, his sui cidal ideation remained markedl y decr eased. He
continues to do well on this triple regimen of bupropion 100 mg bid , fluoxet ine 20
mg, and methylphenidate 10 mg bid , without significant side-e ffec ts .
This patient's experie nce suggests that in cases of severe dep ression th a t fails or
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partially responds to monotherapy, augme ntation th erapy a nd even ECT, th e
triple-therapy described may bring about clinical improvement. T his patient's sus-
tained response is rather encourag ing, given his lon g history of severe a nd frequently
recurrent illn ess. It is postulated th at , via this regimen, levels of ce nt ral serotonin,
norepinephrine and dopamine may be more effec t ively increased , t hereby exer t ing
it s adde d th erapeutic benefit. It is also our opinion th at this form of t r ip le th erapy
represents an additional aug me nta t ion st ra tegy whi ch may be useful in cas es like
th e on e described , or wh en a combina t ion of SRI and eithe r me thylphenidate or
bupropion fails to bring about a full clinical response. C lose r examination involving
larger numbers of such patients is st ill need ed in orde r to subs tantiate th is posit ion.
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